meglumine antimoniate has been researched along with Herpes Zoster in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arboleda, M; Díaz, A; Jaramillo, L; Ortiz, D | 1 |
| Akhdari, N; Amal, S; Hocar, O; Ouadi, Z; Tassi, N | 1 |
2 other study(ies) available for meglumine antimoniate and Herpes Zoster
| Article | Year |
|---|---|
[Cutaneous leishmaniasis and multidermatomic herpes zoster].
Topics: Adult; Antiprotozoal Agents; Female; Herpes Zoster; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Diseases, Viral | 2013 |
[Polymorphic lesions of cutaneous leishmaniasis revealing human immunodeficiency virus infection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Endemic Diseases; Female; Fluconazole; Herpes Zoster; Humans; Immunocompromised Host; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Recurrence; Viremia; Young Adult | 2016 |